Hepatic injury induced by thioacetamide causes aortic endothelial dysfunction by a cyclooxygenase-dependent mechanism

M Nascimento1, R Piran1, R M Da Costa2

  • 1Institute of Health Science, Federal University of Mato Grosso, Sinop, MT, Brazil.

Life Sciences
|October 8, 2018
PubMed

Insights

Liver cirrhosis causes vascular hyporesponsiveness via cyclooxygenase (COX) activation, not nitric oxide (NO). This study in thioacetamide-induced liver injury reveals COX-2

Area of Science:

  • Cardiovascular Physiology
  • Hepatology
  • Pharmacology

Background:

  • Liver cirrhosis is linked to cardiovascular abnormalities like hyperdynamic circulation and cirrhotic cardiomyopathy.
  • Vascular dysregulations are key pathogenic mechanisms contributing to these cardiovascular changes.

Purpose of the Study:

  • To investigate if systemic vascular hyporesponsiveness in thioacetamide (TAA)-induced liver injury is mediated by nitric oxide (NO) or cyclooxygenase (COX) derivatives.
  • To elucidate the role of NO and COX pathways in vascular dysfunction associated with liver injury.

Main Methods:

  • Wistar rats were administered TAA for eight weeks to establish a liver injury model.
  • Aortic contractile responses to phenylephrine were assessed with and without endothelium, L-NAME, and indomethacin.
  • Protein expression of COX-2 and inducible nitric oxide synthase (iNOS) was analyzed.

Main Results:

  • TAA-induced liver injury reduced maximal contractile response to phenylephrine in rat aorta, dependent on the endothelium.
  • Impaired nitric oxide (NO) synthesis was observed, but NO pathways did not explain the reduced contractile response.
  • Cyclooxygenase (COX) inhibition with indomethacin normalized the contractile response, indicating a COX-dependent mechanism.
  • Increased protein expression of COX-2 and iNOS was found in the aorta of TAA-treated rats.
  • Systolic blood pressure was reduced in TAA-treated animals.

Conclusions:

  • Cyclooxygenase-2 (COX-2) activation significantly contributes to extra-hepatic vascular dysfunction in TAA-induced cirrhosis.
  • Inflammatory processes, evidenced by increased COX-2 and iNOS expression, are present in the aorta of rats with liver injury.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.0K
Frequency-dependent Selection01:21

Frequency-dependent Selection

When the fitness of a trait is influenced by how common it is (i.e., its frequency) relative to different traits within a population, this is referred to as frequency-dependent selection. Frequency-dependent selection may occur between species or within a single species. This type of selection can either be positive—with more common phenotypes having higher fitness—or negative, with rarer phenotypes conferring increased fitness.
24.1K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
280
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.9K